Zhang X, Meng Z, Yang C, Wang C, Zhang K, Shi A
Front Genet. 2024; 15:1486252.
PMID: 39737000
PMC: 11683127.
DOI: 10.3389/fgene.2024.1486252.
Zhang J, Wu X, Ma J, Long K, Sun J, Li M
Front Immunol. 2022; 13:967576.
PMID: 36045669
PMC: 9421003.
DOI: 10.3389/fimmu.2022.967576.
Beaumont J, Beelen N, Wieten L, Rouschop K
Cancers (Basel). 2022; 14(16).
PMID: 36010994
PMC: 9406714.
DOI: 10.3390/cancers14164001.
Zhao Y, Fan S, Yuan P, Li G
PLoS One. 2022; 17(3):e0266189.
PMID: 35344574
PMC: 8959171.
DOI: 10.1371/journal.pone.0266189.
Marwarha G, Rosand O, Scrimgeour N, Slagsvold K, Hoydal M
Biomedicines. 2022; 10(1).
PMID: 35052722
PMC: 8772724.
DOI: 10.3390/biomedicines10010042.
miRNA-Mediated Control of B Cell Responses in Immunity and SLE.
Schell S, Rahman Z
Front Immunol. 2021; 12:683710.
PMID: 34079558
PMC: 8165268.
DOI: 10.3389/fimmu.2021.683710.
Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion miR-98-5p in Pediatric IgA Nephropathy.
Liu C, Li X, Shuai L, Dang X, Peng F, Zhao M
Front Pharmacol. 2021; 12:658236.
PMID: 33935780
PMC: 8085534.
DOI: 10.3389/fphar.2021.658236.
MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.
Katsaraki K, Karousi P, Artemaki P, Scorilas A, Pappa V, Kontos C
Cancers (Basel). 2021; 13(4).
PMID: 33546241
PMC: 7913321.
DOI: 10.3390/cancers13040593.
MicroRNA control of B cell tolerance, autoimmunity and cancer.
Xiao C, Nemazee D, Gonzalez-Martin A
Semin Cancer Biol. 2020; 64:102-107.
PMID: 32522353
PMC: 7295097.
DOI: 10.1016/j.semcancer.2019.04.004.
Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension.
Zhao J, Florentin J, Tai Y, Torrino S, Ohayon L, Brzoska T
Circ Res. 2020; 127(5):677-692.
PMID: 32493166
PMC: 7429300.
DOI: 10.1161/CIRCRESAHA.119.316398.
From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.
Frazier S, McBride M, Mulvana H, Graham D
Clin Sci (Lond). 2020; 134(8):1001-1025.
PMID: 32337535
PMC: 7239341.
DOI: 10.1042/CS20200023.
δ-Opioid Receptors, microRNAs, and Neuroinflammation in Cerebral Ischemia/Hypoxia.
Chen Y, He X, Wang S, Xia Y
Front Immunol. 2020; 11:421.
PMID: 32269564
PMC: 7109255.
DOI: 10.3389/fimmu.2020.00421.
MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer.
Bar I, Theate I, Haussy S, Beniuga G, Carrasco J, Canon J
J Histochem Cytochem. 2019; 68(1):25-32.
PMID: 31787032
PMC: 6931165.
DOI: 10.1369/0022155419892965.
MiRNA-210 induces microglial activation and regulates microglia-mediated neuroinflammation in neonatal hypoxic-ischemic encephalopathy.
Li B, Dasgupta C, Huang L, Meng X, Zhang L
Cell Mol Immunol. 2019; 17(9):976-991.
PMID: 31300734
PMC: 7608107.
DOI: 10.1038/s41423-019-0257-6.
Loss of miR-210 leads to progressive retinal degeneration in .
Weigelt C, Hahn O, Arlt K, Gruhn M, Jahn A, Esser J
Life Sci Alliance. 2019; 2(1).
PMID: 30670478
PMC: 6343102.
DOI: 10.26508/lsa.201800149.
The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice.
Zheng B, Xi Z, Liu R, Yin W, Sui Z, Ren B
Front Immunol. 2018; 9:936.
PMID: 29760712
PMC: 5936759.
DOI: 10.3389/fimmu.2018.00936.
Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways.
Watts M, Williams S, Nithianantharajah J, Claudianos C
Noncoding RNA. 2018; 4(2).
PMID: 29657306
PMC: 6027187.
DOI: 10.3390/ncrna4020010.
Metazoan MicroRNAs.
Bartel D
Cell. 2018; 173(1):20-51.
PMID: 29570994
PMC: 6091663.
DOI: 10.1016/j.cell.2018.03.006.
MicroRNA in Immune Regulation.
Wu C, Lu L
Curr Top Microbiol Immunol. 2017; 410:249-267.
PMID: 28900683
PMC: 8476048.
DOI: 10.1007/82_2017_65.
The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer.
Bar I, Merhi A, Abdel-Sater F, Ben Addi A, Sollennita S, Canon J
J Histochem Cytochem. 2017; 65(6):335-346.
PMID: 28402752
PMC: 5625853.
DOI: 10.1369/0022155417702849.